282 related articles for article (PubMed ID: 19271376)
41. Acneiform eruption induced by epidermal growth factor receptor inhibitors in patients with solid tumours.
Jacot W; Bessis D; Jorda E; Ychou M; Fabbro M; Pujol JL; Guillot B
Br J Dermatol; 2004 Jul; 151(1):238-41. PubMed ID: 15270903
[No Abstract] [Full Text] [Related]
42. Ecthymatous skin eruption during therapy with cetuximab.
Navarini AA; Kamacharova I; Kerl K; Donghi D; Cozzio A
Eur J Dermatol; 2011; 21(2):282-3. PubMed ID: 21489913
[No Abstract] [Full Text] [Related]
43. [Skin eruptions as an adverse reaction to epidermal growth-factor receptor inhibitors].
Tjin-A-ton ML; van Montfrans C; Koldenhof JJ; Sigurdsson V; Voest EE; Witteveen PO
Ned Tijdschr Geneeskd; 2007 Apr; 151(17):945-52. PubMed ID: 17520845
[TBL] [Abstract][Full Text] [Related]
44. [Cutaneous toxicity associated with cetuximab treatment in metastatic colorectal cancer].
Rodríguez-Murphy E; Villanueva-Herraiz S; Ortega-García MP; Pérez-Feliu A; López-Montenegro Soria MA; Camps-Herrero C
Farm Hosp; 2011; 35(3):114-20. PubMed ID: 21497124
[TBL] [Abstract][Full Text] [Related]
45. A double-blind, placebo-controlled study of the safety and efficacy of vitamin K1 ointment for the treatment of patients with cetuximab-induced acneiform eruption.
Hashimoto H; Iwasa S; Yanai T; Honma Y; Kato K; Hamaguchi T; Yamada Y; Shimada Y; Namikawa K; Tsutsumida A; Yamazaki N; Yamamoto H
Jpn J Clin Oncol; 2013 Jan; 43(1):92-4. PubMed ID: 23136238
[TBL] [Abstract][Full Text] [Related]
46. Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events.
Lenz HJ
Oncology (Williston Park); 2006 Apr; 20(5 Suppl 2):5-13. PubMed ID: 16736978
[TBL] [Abstract][Full Text] [Related]
47. [Cutaneous side effects of EGF receptor inhibitors].
Nassar D; Soutou B; Aractingi S
Bull Cancer; 2009 Dec; 96 Suppl():S85-91. PubMed ID: 20034874
[TBL] [Abstract][Full Text] [Related]
48. [Acneiform eruption secondary to cetuximab with pseudomalignant histopathological changes].
Vidal-Olmo I; Bassas-Vila J; Herrera-Acosta E; Umbert-Millet P
Actas Dermosifiliogr; 2008 Mar; 99(2):159-60. PubMed ID: 18346444
[No Abstract] [Full Text] [Related]
49. Atypical folliculitis caused by Malassezia spp. in immunosuppressed patients.
Marín-Hernández E; Mejía-Mancera CG; Quijada-Henderson MA; Valero-Gómez A
Bol Med Hosp Infant Mex; 2022; 79(1):62-68. PubMed ID: 35086132
[TBL] [Abstract][Full Text] [Related]
50. Acneiform eruption following molecular targeted chemotherapy.
Vaccaro M; Barbuzza O; Pollicino A; Guarneri C
Intern Med J; 2011 Apr; 41(4):361-2. PubMed ID: 21507168
[No Abstract] [Full Text] [Related]
51. [EGFR (epidermal growth factor receptor) inhibitor-associated skin disorders in tumor therapy].
Reimer G; Brudler O; Heinrich B; Bangerter M
MMW Fortschr Med; 2008 Dec; 150(49-50):37-8, 40. PubMed ID: 19133368
[No Abstract] [Full Text] [Related]
52. [Cutaneous side effects of EGF-receptor inhibition and their management].
Gutzmer R; Werfel T; Kapp A; Elsner J
Hautarzt; 2006 Jun; 57(6):509-13. PubMed ID: 16205868
[TBL] [Abstract][Full Text] [Related]
53. Severe acneiform rash.
Yamamoto DS; Viale PH; Zhao G
Clin J Oncol Nurs; 2004 Dec; 8(6):654-6. PubMed ID: 15637959
[No Abstract] [Full Text] [Related]
54. [Malassezia folliculitis in an immunocompromised patient].
Mota R; Reifenberger J; Homey B; Bruch-Gerharz D
Hautarzt; 2011 Oct; 62(10):725-7. PubMed ID: 21915732
[TBL] [Abstract][Full Text] [Related]
55. Clinical characteristics and treatment outcomes of Pityrosporum folliculitis in immunocompetent patients.
Green M; Feschuk AM; Kashetsky N; Maibach HI
Arch Dermatol Res; 2023 Aug; 315(6):1497-1509. PubMed ID: 36517586
[TBL] [Abstract][Full Text] [Related]
56. Duration of Oral Antibiotics Administration for Cetuximab-Induced Acneiform Eruption.
Park JH; Choi Y; Kim HJ; Oh SJ; Lee DY; Lee JH; Lee JH
Dermatology; 2021; 237(3):457-463. PubMed ID: 33302268
[TBL] [Abstract][Full Text] [Related]
57. A prospective randomized trial of topical pimecrolimus for cetuximab-associated acnelike eruption.
Scope A; Lieb JA; Dusza SW; Phelan DL; Myskowski PL; Saltz L; Halpern AC
J Am Acad Dermatol; 2009 Oct; 61(4):614-20. PubMed ID: 19646778
[TBL] [Abstract][Full Text] [Related]
58. Follicular drug eruption induced by gefitinib (ZD 1839, iressa): clinical picture correlates with in vitro data of focal epidermal necrosis after epidermal growth factor inhibition in skin cultures.
Treudler R; Zouboulis CC
Dermatology; 2005; 211(4):375-6. PubMed ID: 16286753
[No Abstract] [Full Text] [Related]
59. Aripiprazole-induced acneiform eruption.
Mishra B; Praharaj SK; Prakash R; Sinha VK
Gen Hosp Psychiatry; 2008; 30(5):479-81. PubMed ID: 18774434
[TBL] [Abstract][Full Text] [Related]
60. Cetuximab monotherapy in advanced cervical cancer: a retrospective study with five patients.
Hertlein L; Lenhard M; Kirschenhofer A; Kahlert S; Mayr D; Burges A; Friese K
Arch Gynecol Obstet; 2011 Jan; 283(1):109-13. PubMed ID: 20180130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]